These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1009703)

  • 1. The effect of nandrolone decanoate on bone marrow suppression induced by cytostatic agents.
    Huys J; Van Vaerenbergh PM
    Clin Oncol; 1976 Sep; 2(3):207-14. PubMed ID: 1009703
    [No Abstract]   [Full Text] [Related]  

  • 2. Life with cytostatic drugs.
    Van Dam FS; Linssen AC; Engelsman E; van Benthem J; Hanewald GJ
    Eur J Cancer (1965); 1980; Suppl 1():229-33. PubMed ID: 6947892
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anabolic treatment combined with an antimitotic agent in order to prevent leukocyte decrease].
    Biedermann C; Obolensky W; Scoglio P; Zürcher WO
    Ther Umsch; 1966 Dec; 23(12):509-15. PubMed ID: 5980438
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of nandrolone phenylpropionate (Durabolin) on the bone-marrow suppression caused by cyclophosphamide.
    Cooke WM; Burn JI
    Br J Surg; 1971 Apr; 58(4):302-3. PubMed ID: 4929363
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy-induced transverse white lines in the fingernails.
    James WD; Odom RB
    Arch Dermatol; 1983 Apr; 119(4):334-5. PubMed ID: 6340614
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of nandrolone phenylpropionate (NSC-23162e) on the bone marrow suppression caused by cyclophosphamide (NSC-26271): a clinical trial.
    Burn JI; Cooke WM
    Cancer Chemother Rep; 1974; 58(6):867-70. PubMed ID: 4615786
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemoimmunotherapy for advanced renal carcinoma with Adriamycin, bleomycin, vincristine, cyclophosphamide, plus BCG.
    Dana BW; Alberts DS
    Cancer Clin Trials; 1981; 4(2):205-7. PubMed ID: 6166407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematologic findings in leukopenia induced by cytostatics and the autologous bone marrow reinfusion (after 10 years of clinical use)].
    Karrer K; Mannheimer E
    Wien Z Inn Med; 1973; 54(2):51-68. PubMed ID: 4588076
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental chemotherapy in carcinoma of the cervix.
    Papadimitriou G; Razis D; Panopoulos C; Lappas C; Gnafakis N
    Int Surg; 1974 Sep; 59(9):472-5. PubMed ID: 4137657
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stomatitis and antimitotics (author's transl)].
    Cadenat H; Combelles R; Fabert G; Clouet M; Meites-Pero G
    Rev Stomatol Chir Maxillofac; 1978; 79(2):119-20. PubMed ID: 278134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)].
    Robak T; Krykowski E; Płuzańska A; Olszańska-Skorek T; Urbańska-Ryś H; Polkowska-Kulesza E; Błasińska-Morawiec M; Mazurowa A
    Pol Tyg Lek; 1983 Apr; 38(16):481-4. PubMed ID: 6579509
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of rituximab-containing regimens on indolent B-cell lymphoma--a report of 34 cases].
    Xia ZJ; Wang FH; Huang HQ; Luo HY; Li YH; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):490-4. PubMed ID: 16613687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved chemotherapy for small-cell undifferentiated lung cancer.
    Einhorn LH; Fee WH; Farber MO; Livingston RB; Gottlieb JA
    JAMA; 1976 Mar; 235(12):1225-9. PubMed ID: 55504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant histiocytosis. Case report and review.
    Marshall ME
    J Ky Med Assoc; 1983 Jan; 81(1):18-23. PubMed ID: 6687475
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
    Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT
    Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract]   [Full Text] [Related]  

  • 20. Vincristine for treatment of transmissible venereal tumor in the dog--.
    Calvert CA; Leifer CE; MacEwen EG
    J Am Vet Med Assoc; 1982 Jul; 181(2):163-4. PubMed ID: 6749780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.